Three cases of severe hepatic impairment caused by erlotinib.
Huang
Yi-Sheng
YS
An
She-Juan
SJ
Chen
Zhi-Hong
ZH
Wu
Yi-Long
YL
D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000368:Aged; D001706:Biopsy; D000069347:Erlotinib Hydrochloride; D017809:Fatal Outcome; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced* / Q000473:pathology; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride